Welcome to the Journal
Welcome to the International Journal of Cancer Science & Clinical Oncology (IJCSCO), a peer-reviewed, open-access international medical journal with a high impact factor. The journal is dedicated to advancing knowledge in the fields of cancer biology, oncology, clinical research, diagnostics, therapeutics, and patient care. We serve as a global platform for researchers, clinicians, oncologists, and healthcare professionals to publish high-quality research, share innovative findings, and foster scholarly exchange in the evolving landscape of cancer prevention, diagnosis, and treatment.
Publication Frequency
The International Journal of Cancer Science & Clinical Oncology follows a bi-monthly publication schedule, releasing six issues per year. Each issue is published once every two months, ensuring the timely dissemination of peer-reviewed, high-quality research. This consistent frequency reflects the journal’s commitment to staying current with oncological and clinical developments while maintaining rigorous editorial and peer-review standards.
Mission Statement
The mission of IJCSCO is to promote excellence in cancer research, education, and clinical oncology. Our aim is to publish cutting-edge studies that enhance the understanding of cancer biology, innovative diagnostics, targeted therapies, immunotherapies, clinical trials, and their broader implications for global oncology practice.
Scope of the Journal
The journal covers a wide range of topics within cancer science and clinical oncology. It is committed to advancing evidence-based oncology practices and fostering innovation through peer-reviewed publications. We welcome submissions in various formats, including:
• Original Research Articles
• Comprehensive Reviews
• Clinical Case Reports
• Systematic Reviews
• Perspectives and Opinion Pieces
Key areas of focus include but are not limited to:
• Cancer Biology & Molecular Oncology
• Precision & Personalized Oncology
• Immunotherapy & Targeted Therapy
• Radiation & Surgical Oncology
• Chemotherapy Advances
• Cancer Prevention & Early Detection
• Translational & Experimental Oncology
• Biomarkers & Genomics in Cancer
• Clinical Trials & Therapeutics
• Palliative Care & Supportive Oncology
• Cancer Epidemiology & Global Oncology
• Pediatric & Geriatric Oncology
Submissions that provide novel insights, innovative methodologies, or address urgent challenges in oncology are especially encouraged. Please refer to our Aims and Scope page for further details.
Submission Guidelines
We invite oncologists, cancer researchers, and clinical scientists to submit high-quality manuscripts that contribute meaningfully to the field of cancer science and clinical oncology. Acceptable submissions include original research, systematic reviews, case reports, and other scholarly works that enhance global understanding and drive innovation in cancer care.
Peer Review Process
All manuscripts submitted to IJCSCO undergo a rigorous double-blind peer review to ensure the highest standards of scientific integrity and excellence. Each submission is evaluated by independent experts based on scientific merit, originality, methodological quality, and relevance to the journal’s oncology focus. Only research meeting these standards is accepted for publication.
Editorial Board
Our Editorial Board consists of distinguished oncologists, cancer biologists, clinical researchers, and internationally recognized experts. Their expertise, guidance, and commitment to academic excellence uphold the journal’s mission and editorial integrity.
Open Access Policy
The International Journal of Cancer Science & Clinical Oncology is a fully open-access journal. All articles are freely available online without subscription barriers, ensuring unrestricted access to scientific knowledge for oncologists, researchers, clinicians, policy-makers, and the wider public. This model promotes equity, collaboration, and global advancement in cancer research and clinical oncology.
Why Publish with IJCSCO?
• High-Impact Platform: Dedicated to publishing influential oncology research with measurable global impact.
• Rigorous Peer Review: Ensuring scientific accuracy, innovation, and integrity in every publication.
• Uncompromising Quality: Strict editorial and ethical standards for world-class oncology research.
• Global Open Access: Free worldwide access enhances visibility, readership, and citations.
• Increased Academic Recognition: Expands reach among global cancer research communities.
• Author Rights & Licensing: Authors retain copyright under Creative Commons Attribution License (CC BY).
Journal Highlights
• Cancer Biology & Genetics
• Precision Oncology
• Immuno-Oncology
• Chemotherapy & Radiotherapy
• Clinical Trials in Oncology
• Biomarkers & Molecular Diagnostics
• Translational & Experimental Cancer Research
• Cancer Prevention & Screening
• Oncogenomics & Epigenetics
• Pediatric & Geriatric Oncology
• Surgical Oncology & Interventions
• Palliative & Supportive Care
• Oncology Nursing & Patient Care
• Global Cancer Epidemiology
• Nanomedicine in Oncology
• Artificial Intelligence & Digital Oncology
• COVID-19 and Cancer Care
• Comparative Effectiveness Research in Oncology